Search by Drug Name or NDC

    NDC 16714-0963-01 Abiraterone Acetate 250 mg/1 Details

    Abiraterone Acetate 250 mg/1

    Abiraterone Acetate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by NorthStar Rx LLC. The primary component is ABIRATERONE ACETATE.

    Product Information

    NDC 16714-0963
    Product ID 16714-963_564a91be-2efd-3ec5-1996-1491749f271e
    Associated GPIs 21406010200320
    GCN Sequence Number 067349
    GCN Sequence Number Description abiraterone acetate TABLET 250 MG ORAL
    HIC3 V1J
    HIC3 Description ANTINEOPLASTIC - ANTIANDROGENIC AGENTS
    GCN 29886
    HICL Sequence Number 037571
    HICL Sequence Number Description ABIRATERONE ACETATE
    Brand/Generic Generic
    Proprietary Name Abiraterone Acetate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Abiraterone Acetate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name ABIRATERONE ACETATE
    Labeler Name NorthStar Rx LLC
    Pharmaceutical Class Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA208416
    Listing Certified Through 2024-12-31

    Package

    NDC 16714-0963-01 (16714096301)

    NDC Package Code 16714-963-01
    Billing NDC 16714096301
    Package 120 TABLET in 1 BOTTLE (16714-963-01)
    Marketing Start Date 2020-05-19
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.89948
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description ABIRATERONE ACETATE 250 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis